tiprankstipranks
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
PremiumPress ReleasesWindtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
3M ago
Windtree Therapeutics reports Q4 EPS (95c) vs ($13.01) last year
PremiumThe Fly
Windtree Therapeutics reports Q4 EPS (95c) vs ($13.01) last year
3M ago
Windtree Therapeutics enters asset purchase deal with Varian Biopharmaceuticals
PremiumThe Fly
Windtree Therapeutics enters asset purchase deal with Varian Biopharmaceuticals
3M ago
Windtree Therapeutics renews agreement with Chang Gung University
PremiumThe FlyWindtree Therapeutics renews agreement with Chang Gung University
6M ago
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
PremiumPress Releases
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
6M ago
Windtree Therapeutics Seeks Strategic Alternatives with Ladenburg Thalmann
PremiumCompany Announcements
Windtree Therapeutics Seeks Strategic Alternatives with Ladenburg Thalmann
6M ago
Windtree Therapeutics eliminates $15M contingent liability to Deerfield
PremiumThe FlyWindtree Therapeutics eliminates $15M contingent liability to Deerfield
6M ago
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
PremiumPress Releases
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
6M ago
Windtree Therapeutics announces license agreement with Lee’s Pharmaceuticals
PremiumThe Fly
Windtree Therapeutics announces license agreement with Lee’s Pharmaceuticals
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100